Expediting Psychedelic Research to Qualify for Right to Try

Event ID: PP1162273

Wed, Mar 18, 2026 | 4:30 PM - 5:30 PM

Venue: Salon C (JW Marriott)

View on Official SXSW

Summary

This session explores psychedelic science and federal Right to Try (RTT) law, which allows patients with life-threatening conditions to access investigational treatments outside of clinical trials. Featuring experts who helped pass historic psychedelic research legislation in Texas and Arizona, the panel will examine the scientific, legal, and ethical considerations of making these powerful but under-researched compounds accessible under RTT. Discussion will cover the current state of psychedelic research, pathways to FDA authorization, and how to qualify for compassionate use of psychedelics.

Contributors

Raw Event JSON

Large nested arrays are compacted for page readability. Full payload remains in dataset files.

Open JSON payload
{
  "id": "PP1162273",
  "track": "Health",
  "focus_area": null,
  "category": "Presentation",
  "event_id": "PP1162273",
  "event_type": "panel",
  "format": "Presentation",
  "genre": null,
  "subgenre": null,
  "name": "Expediting Psychedelic Research to Qualify for Right to Try",
  "presented_by": null,
  "publish_at": "2025-11-04T10:09:00.000-06:00",
  "reservable": true,
  "reservable_id": "PP1162273",
  "reserved": false,
  "date": "2026-03-18",
  "end_time": "2026-03-18T12:30:00.000-05:00",
  "start_time": "2026-03-18T11:30:00.000-05:00",
  "message": null,
  "image": {
    "alt_text": "Expediting Psychedelic Research to Qualify for Right to Try",
    "credit": null,
    "url": "https://images.sxsw.com/J6AldgV8J_dk3_RZjEfV56uKiIQ=/950x633/images.sxsw.com/187/04329d76-5a76-a649-e28c-f60c99829bc4/pp1162273"
  },
  "credentials": [
    {
      "name": "Platinum Badge",
      "type": "platinum"
    },
    {
      "name": "Innovation Badge",
      "type": "innovation"
    }
  ],
  "contributors": [
    {
      "id": 79049,
      "company": "Veterans Exploring Treatment Solutions (VETS) & Texans For Greater Mental Health (T4GMH)",
      "credential_types": [
        "innovation"
      ],
      "entity_id": 2240065,
      "name": "Logan Davidson",
      "speaker_types": [
        "Speaker"
      ],
      "title": "Legislative Director",
      "image": {
        "alt_text": "Logan Davidson",
        "credit": null,
        "url": "https://images.sxsw.com/dqp2SfvVsxo_TfQgtRjl294nR2g=/600x600/images.sxsw.com/48/cbd51b69-bba7-001b-f587-9c5c94515c51/pcid-1625835"
      },
      "speaker_type": "Speaker",
      "details": null,
      "links": {},
      "type": "person"
    },
    {
      "id": 576,
      "company": "Scottsdale Research Institute/Field To Healed Foundation",
      "credential_types": [
        "innovation"
      ],
      "entity_id": 3445,
      "name": "Dr. Sue Sisley, MD",
      "speaker_types": [
        "Speaker"
      ],
      "title": "Principal Investigator & CMO",
      "image": {
        "alt_text": "Dr. Sue Sisley, MD",
        "credit": null,
        "url": "https://images.sxsw.com/s6dgCuRWHYZ1LPigBhFtX37Oafs=/0x523:2659x3182/600x600/images.sxsw.com/48/83feed6f-91a7-4c9f-b4de-fd240fac0293/pcid-835744"
      },
      "speaker_type": "Speaker",
      "details": "Dr. Sue Sisley, MD is Montana/Arizona-based physician practicing Internal Medicine & Psychiatry. Sue serves as Principal Investigator of nonprofit Scottsdale Research Institute for myriad FDA-approved randomized controlled trials examining safety/efficacy of LSD, psilocybin mushrooms & intact cannabis flower. Sue holds 7 different DEA schedule 1 licenses as researcher & manufacturer. 5 years ago, SRI secured the only DEA schedule 1 manufacturer license in US for farming whole cannabis flower & natural psilocybin mushrooms instead of synthetic molecule. Her current Cannabis research is FDA phase 2b trial examining inhaled cannabis flower in 320 military veterans with pain/PTSD.  SRI received greenlight from FDA to perform 1st ever controlled trial with intact, natural P. Cubensis mushrooms.",
      "links": {},
      "type": "person"
    }
  ],
  "venue": {
    "accessible": false,
    "age_policy": null,
    "floor": "3",
    "id": "V0453",
    "indoor_outdoor": "INDOOR",
    "mixhalo_url": "https://translate.mixhalo.rocks/430?venue_id=430&partner=true",
    "name": "Salon C",
    "parent_id": "V0403",
    "parent_venue_name": "JW Marriott",
    "venue_entry_info": null,
    "formats": null,
    "location": {
      "address": "110 E 2nd St.",
      "lat_lon": [
        30.2645713,
        -97.743198
      ],
      "city": "Austin",
      "postal_code": "78701",
      "state": "TX",
      "name": "JW Marriott"
    },
    "root": {
      "id": "V0403",
      "name": "JW Marriott",
      "mixhalo_url": null
    },
    "events": "[omitted 5 venue events]"
  },
  "description": "This session explores psychedelic science and federal Right to Try (RTT) law, which allows patients with life-threatening conditions to access investigational treatments outside of clinical trials. Featuring experts who helped pass historic psychedelic research legislation in Texas and Arizona, the panel will examine the scientific, legal, and ethical considerations of making these powerful but under-researched compounds accessible under RTT. Discussion will cover the current state of psychedelic research, pathways to FDA authorization, and how to qualify for compassionate use of psychedelics.",
  "experience_level": "Intermediate",
  "audio_url": null,
  "accessibility": [
    "Closed captioned"
  ],
  "accessible_venue": false,
  "add_bcl_url": false,
  "add_slido": false,
  "after_midnight": null,
  "age_policy": null,
  "american_sign_language": false,
  "apple_url": null,
  "audio_description": false,
  "caption_url": null,
  "captioned_qa": false,
  "closed_captioned": true,
  "cpe_credit": false,
  "event_status": "none",
  "has_subtitles": false,
  "hash_tags": [],
  "high_sensory_experience": false,
  "live": false,
  "long_description": "This session explores psychedelic science and federal Right to Try (RTT) law, which allows patients with life-threatening conditions to access investigational treatments outside of clinical trials. Featuring experts who helped pass historic psychedelic research legislation in Texas and Arizona, the panel will examine the scientific, legal, and ethical considerations of making these powerful but under-researched compounds accessible under RTT. Discussion will cover the current state of psychedelic research, pathways to FDA authorization, and how to qualify for compassionate use of psychedelics.",
  "meeting_url": null,
  "meeting_url_live": false,
  "mentorly_url": null,
  "mobile_audio_url": null,
  "open_captioned": false,
  "playlist_tag": null,
  "rebroadcast": false,
  "recommended_ids": [],
  "search_conversions": null,
  "short_program": false,
  "slido_url": null,
  "sort": "EXPEDITING PSYCHEDELIC RESEARCH TO QUALIFY FOR RIGHT TO TRY",
  "source": "Official",
  "squad_up_url": null,
  "stream_embed": null,
  "stream_id": null,
  "stream_url": null,
  "strobe_warning": false,
  "subdiscipline": null,
  "summit": null,
  "summit_display_name": null,
  "tags": [
    {
      "id": 943,
      "name": "Policy",
      "created_at": "2016-11-03T15:56:26.812-05:00",
      "updated_at": "2024-02-05T17:28:34.060-06:00",
      "sort": "POLICY",
      "alpha": "P"
    },
    {
      "id": 2484,
      "name": "Psychedelics",
      "created_at": "2024-02-13T18:44:03.535-06:00",
      "updated_at": "2024-02-13T18:44:03.535-06:00",
      "sort": "PSYCHEDELICS",
      "alpha": "P"
    }
  ],
  "talent_attending": null,
  "title_only": false,
  "track_display_name": "Health track sponsored by Eli Lilly",
  "trailer_id": null,
  "trailer_url": null,
  "video_on_demand": null,
  "vimeo_id": null,
  "vod": false,
  "xr_project_type": null,
  "youtube_id": null,
  "related_events": [],
  "related_sales_client": null
}